About Us
Index / About Us /R&D
Index / About Us / R&D

Improve People's Quality of Life

Regarding the rising health insurance expenses, we actively developed the "Self-Care" series of products in response to the concept of self-medication promoted by the government, provide patients and sub-health individuals with more flexibility to choose suitable drugs and health products with convenience. Consumers will be able to obtain safe and effective medicines within a short time. Such development aims at improving people's quality of life and reducing the national health insurance expenses, and the limited health care resources may, therefore, be utilized more effectively for those in need.

R&D Strategy, Preparation R&D

Chung Mei's development strategy focuses on the preparation R&D; the development aims at safety, efficacy, stability, and practicability. With OTC drugs and generic drugs developed and launched by top 10 advanced countries as our development theme, we continuously improve our new drug R&D regarding the quality of preparation. We focus on, the development of new formulations, new compounds, new curative effect or new usage. We collaborate with national academic institutes or CRO companies to conduct formula design, clinical trials, BA/BE test, etc., so as to further enhance the R&D capacity.